シムリン（プラムリンチド）の世界市場 2020年

• 英文タイトル：Global Symlin (pramlintide) Market 2020 by Company, Regions, Type and Application, Forecast to 2025

• レポートコード：GIR201115221 • 出版社/出版日：GlobalInfoResearch / 2020年10月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医薬品・医療

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本書では、シムリン（プラムリンチド）の世界市場を調査対象にし、シムリン（プラムリンチド）の市場概要、企業情報、企業別売上・市場シェア、地域別市場分析（北米、アメリカ、ヨーロッパ、アジア、日本、中国、南米、中東・アフリカ）、種類別分析（1.5mlペンインジェクター、2.7mlペンインジェクター）、用途別分析（I型糖尿病、II型糖尿病）、市場予測（2021年～2025年）情報などを整理しました。 ・市場概要 ・企業情報：AstraZeneca ・企業別売上、市場シェア ・シムリン（プラムリンチド）の地域別市場分析 ・シムリン（プラムリンチド）の北米市場規模2015-2020：アメリカ、カナダ、メキシコ ・シムリン（プラムリンチド）のヨーロッパ市場規模2015-2020：ドイツ、イギリス、フランス、ロシアなど ・シムリン（プラムリンチド）のアジア市場規模2015-2020：日本、中国、韓国、インド、東南アジアなど ・シムリン（プラムリンチド）の南米市場規模2015-2020：ブラジル、アルゼンチンなど ・シムリン（プラムリンチド）の中東・アフリカ市場規模2015-2020：サウジアラビア、トルコ、エジプト、南アフリカなど ・シムリン（プラムリンチド）の種類別市場規模2015-2020：1.5mlペンインジェクター、2.7mlペンインジェクター ・シムリン（プラムリンチド）の用途別市場規模2015-2020：I型糖尿病、II型糖尿病 ・シムリン（プラムリンチド）の世界市場予測2021-2025：地域別、種類別、用途別 ・調査の結果・結論

Market Overview
The global Symlin (pramlintide) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Symlin (pramlintide) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Symlin (pramlintide) market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Symlin (pramlintide) market has been segmented into:
1.5ml pen-injector
2.7ml pen-injector

By Application, Symlin (pramlintide) has been segmented into:
Type I diabetes
Type II diabetes

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Symlin (pramlintide) market presented in the report. This section sheds light on the sales growth of different regional and country-level Symlin (pramlintide) markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Symlin (pramlintide) market.

The report offers in-depth assessment of the growth and other aspects of the Symlin (pramlintide) market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Competitive Landscape and Symlin (pramlintide) Market Share Analysis
Symlin (pramlintide) competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Symlin (pramlintide) sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Symlin (pramlintide) sales, revenue and market share for each player covered in this report.

The major players covered in Symlin (pramlintide) are:
AstraZeneca

レポート目次

---

1 Symlin (pramlintide) Market Overview
1.1 Product Overview and Scope of Symlin (pramlintide)
1.2 Classification of Symlin (pramlintide) by Type
1.2.1 Global Symlin (pramlintide) Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Symlin (pramlintide) Revenue Market Share by Type in 2019
1.2.3 1.5ml pen-injector
1.2.4 2.7ml pen-injector
1.3 Global Symlin (pramlintide) Market by Application
1.3.1 Overview: Global Symlin (pramlintide) Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Type I diabetes
1.3.3 Type II diabetes
1.4 Global Symlin (pramlintide) Market by Regions
1.4.1 Global Symlin (pramlintide) Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Symlin (pramlintide) (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Symlin (pramlintide) Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Symlin (pramlintide) Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Symlin (pramlintide) Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Symlin (pramlintide) Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Symlin (pramlintide) Status and Prospect (2015-2025)
2 Company Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 AstraZeneca SWOT Analysis
2.1.4 AstraZeneca Product and Services
2.1.5 AstraZeneca Symlin (pramlintide) Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Symlin (pramlintide) Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Symlin (pramlintide) Players Market Share
3.2.2 Top 10 Symlin (pramlintide) Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Symlin (pramlintide) Revenue and Market Share by Regions
4.2 North America Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
4.3 Europe Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
4.5 South America Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
5 North America Symlin (pramlintide) Revenue by Countries
5.1 North America Symlin (pramlintide) Revenue by Countries (2015-2020)
5.2 USA Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
5.3 Canada Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
5.4 Mexico Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
6 Europe Symlin (pramlintide) Revenue by Countries
6.1 Europe Symlin (pramlintide) Revenue by Countries (2015-2020)
6.2 Germany Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
6.3 UK Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
6.4 France Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
6.5 Russia Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
6.6 Italy Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Symlin (pramlintide) Revenue by Countries
7.1 Asia-Pacific Symlin (pramlintide) Revenue by Countries (2015-2020)
7.2 China Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
7.3 Japan Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
7.4 Korea Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
7.5 India Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
8 South America Symlin (pramlintide) Revenue by Countries
8.1 South America Symlin (pramlintide) Revenue by Countries (2015-2020)
8.2 Brazil Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
8.3 Argentina Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Symlin (pramlintide) by Countries
9.1 Middle East & Africa Symlin (pramlintide) Revenue by Countries (2015-2020)
9.2 Saudi Arabia Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
9.3 UAE Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
9.4 Egypt Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
9.5 South Africa Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Symlin (pramlintide) Revenue and Market Share by Type (2015-2020)
10.2 Global Symlin (pramlintide) Market Forecast by Type (2019-2024)
10.3 1.5ml pen-injector Revenue Growth Rate (2015-2025)
10.4 2.7ml pen-injector Revenue Growth Rate (2015-2025)
11 Global Symlin (pramlintide) Market Segment by Application
11.1 Global Symlin (pramlintide) Revenue Market Share by Application (2015-2020)
11.2 Symlin (pramlintide) Market Forecast by Application (2019-2024)
11.3 Type I diabetes Revenue Growth (2015-2020)
11.4 Type II diabetes Revenue Growth (2015-2020)
12 Global Symlin (pramlintide) Market Size Forecast (2021-2025)
12.1 Global Symlin (pramlintide) Market Size Forecast (2021-2025)
12.2 Global Symlin (pramlintide) Market Forecast by Regions (2021-2025)
12.3 North America Symlin (pramlintide) Revenue Market Forecast (2021-2025)
12.4 Europe Symlin (pramlintide) Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Symlin (pramlintide) Revenue Market Forecast (2021-2025)
12.6 South America Symlin (pramlintide) Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Symlin (pramlintide) Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US

List of Tables
Table 1. Global Symlin (pramlintide) Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Symlin (pramlintide) by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Symlin (pramlintide) Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Symlin (pramlintide) Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. AstraZeneca Corporate Information, Location and Competitors
Table 6. AstraZeneca Symlin (pramlintide) Major Business
Table 7. AstraZeneca Symlin (pramlintide) Total Revenue (USD Million) (2017-2018)
Table 8. AstraZeneca SWOT Analysis
Table 9. AstraZeneca Symlin (pramlintide) Product and Solutions
Table 10. AstraZeneca Symlin (pramlintide) Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Global Symlin (pramlintide) Revenue (Million USD) by Players (2015-2020)
Table 12. Global Symlin (pramlintide) Revenue Share by Players (2015-2020)
Table 13. Global Symlin (pramlintide) Revenue (Million USD) by Regions (2015-2020)
Table 14. Global Symlin (pramlintide) Revenue Market Share by Regions (2015-2020)
Table 15. North America Symlin (pramlintide) Revenue by Countries (2015-2020)
Table 16. North America Symlin (pramlintide) Revenue Market Share by Countries (2015-2020)
Table 17. Europe Symlin (pramlintide) Revenue (Million USD) by Countries (2015-2020)
Table 18. Asia-Pacific Symlin (pramlintide) Revenue (Million USD) by Countries (2015-2020)
Table 19. South America Symlin (pramlintide) Revenue by Countries (2015-2020)
Table 20. South America Symlin (pramlintide) Revenue Market Share by Countries (2015-2020)
Table 21. Middle East and Africa Symlin (pramlintide) Revenue (Million USD) by Countries (2015-2020)
Table 22. Middle East and Africa Symlin (pramlintide) Revenue Market Share by Countries (2015-2020)
Table 23. Global Symlin (pramlintide) Revenue (Million USD) by Type (2015-2020)
Table 24. Global Symlin (pramlintide) Revenue Share by Type (2015-2020)
Table 25. Global Symlin (pramlintide) Revenue Forecast by Type (2021-2025)
Table 26. Global Symlin (pramlintide) Revenue by Application (2015-2020)
Table 27. Global Symlin (pramlintide) Revenue Share by Application (2015-2020)
Table 28. Global Symlin (pramlintide) Revenue Forecast by Application (2021-2025)
Table 29. Global Symlin (pramlintide) Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Symlin (pramlintide) Picture
Figure 2. Global Symlin (pramlintide) Revenue Market Share by Type in 2019
Figure 3. 1.5ml pen-injector Picture
Figure 4. 2.7ml pen-injector Picture
Figure 5. Symlin (pramlintide) Revenue Market Share by Application in 2019
Figure 6. Type I diabetes Picture
Figure 7. Type II diabetes Picture
Figure 8. Global Symlin (pramlintide) Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Symlin (pramlintide) Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Symlin (pramlintide) Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Symlin (pramlintide) Revenue Market Share in 2019
Figure 17. Global Top 10 Players Symlin (pramlintide) Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Symlin (pramlintide) Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Symlin (pramlintide) Revenue Market Share by Regions (2015-2020)
Figure 21. Global Symlin (pramlintide) Revenue Market Share by Regions in 2018
Figure 22. North America Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 23. Europe Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 25. South America Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 27. North America Symlin (pramlintide) Revenue Market Share by Countries (2015-2020)
Figure 28. North America Symlin (pramlintide) Revenue Market Share by Countries in 2019
Figure 29. USA Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 30. Canada Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 32. Europe Symlin (pramlintide) Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Symlin (pramlintide) Revenue Market Share by Countries in 2019
Figure 34. Germany Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 35. UK Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 36. France Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 37. Russia Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 38. Italy Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Symlin (pramlintide) Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Symlin (pramlintide) Revenue Market Share by Countries in 2019
Figure 41. China Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 42. Japan Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 43. Korea Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 44. India Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 46. South America Symlin (pramlintide) Revenue Market Share by Countries (2015-2020)
Figure 47. South America Symlin (pramlintide) Revenue Market Share by Countries in 2019
Figure 48. Brazil Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Symlin (pramlintide) Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Symlin (pramlintide) Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 53. UAE Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Symlin (pramlintide) Revenue and Growth Rate (2015-2020)
Figure 56. Global Symlin (pramlintide) Revenue Share by Type (2015-2020)
Figure 57. Global Symlin (pramlintide) Revenue Share by Type in 2019
Figure 58. Global Symlin (pramlintide) Market Share Forecast by Type (2021-2025)
Figure 59. Global 1.5ml pen-injector Revenue Growth Rate (2015-2020)
Figure 60. Global 2.7ml pen-injector Revenue Growth Rate (2015-2020)
Figure 61. Global Symlin (pramlintide) Revenue Share by Application (2015-2020)
Figure 62. Global Symlin (pramlintide) Revenue Share by Application in 2019
Figure 63. Global Symlin (pramlintide) Market Share Forecast by Application (2021-2025)
Figure 64. Global Type I diabetes Revenue Growth Rate (2015-2020)
Figure 65. Global Type II diabetes Revenue Growth Rate (2015-2020)
Figure 66. Global Symlin (pramlintide) Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Symlin (pramlintide) Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Symlin (pramlintide) Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Symlin (pramlintide) Revenue Market Forecast (2021-2025)
Figure 70. Europe Symlin (pramlintide) Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Symlin (pramlintide) Revenue Market Forecast (2021-2025)
Figure 72. South America Symlin (pramlintide) Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Symlin (pramlintide) Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel

---